Nelveg-Kristensen_2016_Pharmacogenet.Genomics_26_169

Reference

Title : Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitors - Nelveg-Kristensen_2016_Pharmacogenet.Genomics_26_169
Author(s) : Nelveg-Kristensen KE , Madsen MB , Torp-Pedersen C , Kober L , Egfjord M , Hansen T , Pedersen O , Rasmussen HB , Hansen PR
Ref : Pharmacogenet Genomics , 26 :169 , 2016
Abstract : Nelveg-Kristensen_2016_Pharmacogenet.Genomics_26_169
ESTHER : Nelveg-Kristensen_2016_Pharmacogenet.Genomics_26_169
PubMedSearch : Nelveg-Kristensen_2016_Pharmacogenet.Genomics_26_169
PubMedID: 26761119
Gene_locus related to this paper: human-CES1

Related information

Gene_locus related to this paper: human-CES1

Citations formats

Nelveg-Kristensen KE, Madsen MB, Torp-Pedersen C, Kober L, Egfjord M, Hansen T, Pedersen O, Rasmussen HB, Hansen PR (2016)
Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitors
Pharmacogenet Genomics 26 :169

Nelveg-Kristensen KE, Madsen MB, Torp-Pedersen C, Kober L, Egfjord M, Hansen T, Pedersen O, Rasmussen HB, Hansen PR (2016)
Pharmacogenet Genomics 26 :169